Osiris Therapeutics (Osiris Therapeutics) Days Payable : 39.25 (As of Dec. 2018)

View and export this data going back to 2006. Start your Free Trial

What is Osiris Therapeutics Days Payable?

Osiris Therapeutics's average Accounts Payable for the three months ended in Dec. 2018 was $4.2 Mil. Osiris Therapeutics's Cost of Goods Sold for the three months ended in Dec. 2018 was $9.8 Mil. Hence, Osiris Therapeutics's Days Payable for the three months ended in Dec. 2018 was 39.25.

The historical rank and industry rank for Osiris Therapeutics's Days Payable or its related term are showing as below:

OSIR's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 153.86
* Ranked among companies with meaningful Days Payable only.

Osiris Therapeutics's Days Payable declined from Dec. 2017 (51.83) to Dec. 2018 (39.25). It may suggest that Osiris Therapeutics accelerated paying its suppliers.

Osiris Therapeutics Days Payable Historical Data

The historical data trend for Osiris Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Osiris Therapeutics Days Payable Chart

Osiris Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Days Payable

Get a 7-Day Free Trial

64.15

61.21

60.47

45.04

Osiris Therapeutics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18
Days Payable	Get a 7-Day Free Trial															51.83	57.27	53.28	45.32	39.25

Competitive Comparison of Osiris Therapeutics's Days Payable

For the Biotechnology subindustry, Osiris Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Osiris Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Osiris Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Osiris Therapeutics's Days Payable falls into.

Osiris Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Osiris Therapeutics's Days Payable for the fiscal year that ended in Dec. 2018 is calculated as

	Days Payable (A: Dec. 2018 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2017 )	+	Accounts Payable (A: Dec. 2018 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2018 )	*	Days in Period
=	( (5.269	+	4.144)	/	2 )	/	38.139	*	365
=	4.7065					/	38.139	*	365
=	45.04

Osiris Therapeutics's Days Payable for the quarter that ended in Dec. 2018 is calculated as:

	Days Payable (Q: Dec. 2018 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2018 )	+	Accounts Payable (Q: Dec. 2018 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2018 )	*	Days in Period
=	( (4.291	+	4.144)	/	2 )	/	9.806	*	365 / 4
=	4.2175					/	9.806	*	365 / 4
=	39.25

Osiris Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Osiris Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Osiris Therapeutics (Osiris Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Osiris Therapeutics Inc (NAS:OSIR) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

7015 Albert Einstein Drive, Columbia, MD, USA, 21046-1707

Website

http://www.osiris.com

Osiris Therapeutics is a biotechnology company involved in researching, developing, and marketing cellular regenerative medicine products. The company's therapeutic areas focus on innovation in regenerative medicine, including bioengineering, stem cell research, and viable tissue-based products. Osiris has accomplished commercial success with products in orthopedics, sports medicine, and wound care, such as Cartiform, Ovation, and Grafix.

Executives

Reinhart Charles A. Iii	director	C/O PACIRA PHARMACEUTICALS, INC., 5 SYLVAN WAY, SUITE 300, PARSIPPANY NJ 07054
Linda L Chang	officer: Chief Financial Officer	ONE PARK PLACE, STE 450, ANNAPOLIS MD 21401
Shauna L Vernal	officer: Chiel Legal Officer
Linda Palczuk	officer: President & CEO	7015 ALBERT EINSTEIN DRIVE, COLUMBIA MD 21046
David L White	director
Thomas J Knapp	director	4640 SW MACADAM AVE., SUITE 270, PORTLAND OR 97239
Jonathan Mark Hopper	officer: Chief Medical Officer	64 SIDNEY STREET, CAMBRIDGE MA 02139
Jacoby Philip R Jr	officer: Principal Accounting Officer
C Randal Mills	director, officer: President & CEO	18366 CALLE STELLINA, RANCHO SANTA FE CA 92091
Jay M Moyes	director
Stephen W Potter	officer: Senior Vice President	7015 ALBERT EINSTEIN DR, COLUMBIA MD 21046
Gregory Hurd Barnhill	director